Beluga Portal

Wesley Phillips

Male · 1/28/1987 (38y) · OR menuDots

Phone: 5039293446

All Visits (1)

Weightloss

Master Id: rxreq_b44sj8irrgbzue6ss3puggq2

Active

Current Visit

Created on: 4-21-2025

Updated on: 4-21-2025

foundationGobyMeds Weightloss

Active Visit

Master Id: rxreq_b44sj8irrgbzue6ss3puggq2

First Name	Wesley
Last Name	Phillips
Date of Birth	01/28/1987
Phone Number	5039293446
Email	wesphillips.pa@gmail.com
Address	3733 Southeast 69th Avenue
City	Portland
State	OR
Zip	97206
Sex	Male
Self-reported Meds	Meloxicam
Allergies	Tree nuts, carrots, fish
Medical Conditions	None
Patient preference	Name: Pharmacyhub Semaglutide starter (3 month) quantity: 2.5 strength: 2.5mg/ml refills: 0 MedId: 0iNQ4Bzjla0nFd9e1rCtBTpax40lsIWd Name: GLP-1 Injection Kit 1 ml syringe - Quarterly - Pharmacy Hub quantity: 1 strength: None provided refills: 0 MedId: bcA8LzvVTABsJGWA74EBtS4j7iFplvA1
Consents for telemedicine and privacy policy signed?	true
Are you currently taking a GLP-1 Medication? I'm just starting out I am currently taking a GLP-1 medication	I am currently taking a GLP-1 medication
Do you have a recent prescription (within the last two months) for a GLP-1 medication such as Ozempic, Wegovy, Zepbound, Mounjaro, Semaglutide, or Tirzepatide? Yes No	Yes
Which medication are you prescribed? Semaglutide Injection (Ozempic / Wegovy / Compounded) Oral Semaglutide (Rybelsus / Compounded) Tirzepatide Injection (Mounjaro / Zepbound / Compounded)	Semaglutide Injection (Ozempic / Wegovy / Compounded)
Which dosage of your prescribed medication most closely matches your most recent dosage? Semaglutide Injection 0.25mg Semaglutide Injection 0.5mg Semaglutide Injection 1mg Semaglutide Injection 1.7mg Semaglutide Injection 2.4mg Tirzepatide Injection 2.5mg Tirzepatide Injection 5mg Tirzepatide Injection 7.5mg Tirzepatide Injection 10mg Tirzepatide Injection 12.5mg Tirzepatide Injection 15mg Oral Semaglutide Tablet 3mg Oral Semaglutide Tablet 7mg Oral Semaglutide Tablet 14mg Oral Semaglutide Tablet 21mg	Semaglutide Injection 0.25mg
Do you have any side effects at your current dosage? (Leave blank if none)	None
How would you like to continue your treatment? Remain at current (or equivalent) dosage Increase my dosage Decrease my dosage	Increase my dosage
What is your Height?	5' 10"
What is your current weight in lbs?	224
What is your BMI?	32.14
Do you currently or have you ever had any of the following conditions or procedures? Gastroparesis. Inflammatory bowel disease. Pancreatitis. Pancreatic cancer. Advanced Kidney disease. Insulin-dependent diabetes. Thyroid cancer. Family history of thyroid cancer. Family history of MEN-2 syndrome. PCOS with fertility problems. Eating disorder, past or present. Suicidal thoughts in the past 12 months. Anorexia or bulimia. Gastric bypass in the past 6 months. Yes No	No
Do you currently or have you ever had Gallbladder disease? Yes No	No
Do you currently or have you ever had Hypertriglyceridemia (elevated triglycerides)? Yes No	No
Are you allergic to any of the following: Semaglutide (Ozempic / Wegovy), Tirzepatide (Mounjaro / Zepbound), or Liraglutide (Saxenda)? Yes No	No
Do you take any of the following medications? Insulin, Glimepiride (Amaryl), Glipizide (Glucotrol and Glucotrol XL), Glyburide (Micronase, Glynase, and Diabeta), Sitagliptin, Saxagliptin, Linagliptin, Alogliptin Yes No	No
What other information or questions do you have for the doctor?	N/A
Do you confirm you are the patient and attest that the information provided is true to best of your knowledge? I verify that I am the patient and have completed the intake form and acknowledge the following. I have reviewed, understand, and attest that the information I have provided above is true to best of my knowledge. I understand that it is critical to my health to share complete health information with my doctor. I will not hold the doctor or affiliated medical practice responsible for any oversights or omissions, whether intentional or not in the information that I provided above. Yes	Yes
Do you acknowledge the general guidelines for the product, off-label use and it’s side effects? The traditional use of weight loss medications is for individuals with a BMI of 30 and above or to those who are overweight who have associated health conditions. Using it for someone in the BMI range (27-29) without an accompanying health condition is termed "off-label." Using a medication "off-label" refers to the practice of prescribing a drug for a purpose, age group, dosage, or form of administration that is not included in the approved labelling by regulatory agencies like the U.S Food and Drug administration (FDA). While a medication undergoes rigorous testing for specific uses before receiving approval, healthcare providers may discover through clinical experience or research that it can be effective for treating other conditions. There may be benefits such as weight reduction for individuals within your range. If you agree to this off label use, it's crucial to follow the prescribed regimen and report any concerns. Please discuss any questions with us. Yes	Yes

Medicine Selection

Pharmacy:THE PHARMACY HUB LLC

Search Medication

Deselect All

GLP-1 Injection Kit 1 ml syringe - Quarterly - Pharmacy Hub

PharmacyHub GLP-1 Injection Kit

PharmacyHub GLP-1 Injection Kit 1 ml syringe - Semiannual

Pharmacyhub Semaglutide starter (3 month)

Assessment & Plan (Internal Note)

Patient has been educated on the treatment plan including instructions for use, risks/benefits/side effects.
No contraindications, red flags, or dangerous polypharmacy interactions identified.
If any side effects occur they should discontinue use and contact me for further instruction, except in the case of severe side effects in which case they should seek urgent care in an emergency room.
FOLLOW UP: The patient has been provided information on how to contact our medical team to follow up if any medical concerns or reactions to treatment arise at any time.
The patient is recommended to follow up with myself or the support team if additional concerns arise or the treatment plan needs to be adjusted.
Patient has been educated that there are limitations to telemedicine care, and in-person care may be necessary in certain situations (ER if severe side effects develop or through an in-person physician if signs/symptoms develop that warrant additional work up/evaluation/alternative treatments).
To the extent that I have been made aware by the company with which I contract to provide medical services,
the patient has signed relevant attestations prior to being assigned to me as a clinician that state that the patient is aware of any limitations in a virtual health encounter and understands that urgent or emergent care must be pursued in person.
I have confirmed the patient's identity via review of a legally recognized form of ID or through a second party identity verification service.
Please see doctor/patient messaging thread for any relevant dialogue which, in addition to providing supplemental medical information as needed, secures and meets the legally-defined doctor-patient relationship.
Telemedicine is appropriate for this patient encounter because it can meet the same standard of care for this patient's chief complaint and can improve access to care which remains limited in many parts of the United States.